DIGITEX (DIGOXIN TABLETS)

      

  On April 25, 2008, Actavis Totowa, L.L.C., initiated a nationwide recall of Digitek (Digoxin Tablets) for oral use.  The recall affected all strengths of Digitek.  Digitek had been distributed by Mylan Pharmaceuticals, Inc., under a “Bertek” label and by UDL Laboratories, Inc., under a “UDL” label.

   The voluntary recall of Digitek consisted of an all lot recall due to the possibility that tablets with double the appropriate thickness may have been commercially released.  The tablets may contain twice the approved level of active ingredient than is appropriate. 

   Digitek is used to treat heart failure and abnormal heart rhythms.  The existence of double strength tablets poses a risk of Digitalis toxicity in patients with renal failure.  Digitalis toxicity can also cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia.  Death can also result from excessive Digitalis intake.  There have been several reports of illness and injuries received by the manufacturer at the time of the recall.

   Digitek is the brand name for Digoxin tablets either in 0.125 mg or 0.25 mg.  Digitek is prescribed for oral use to treat heart failure and abnormal heart rhythms.

    Should you believe either you or a member of your family has suffered a complication with the use of Digitek, feel free to call one of the lawyers in our firm at no cost to you.